NEW YORK, June  26, 2026  (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Nano-X Imaging Ltd. (&#34;Nano-X&#34; or the &#34;Company&#34;) (NASDAQ:NNOX) securities to contact Lauren Molinaro of

NNOX

NNOX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Nano-X Imaging Ltd. Investors - Contact Kirby McInerney LLP by August 11, 2026

Nano-X faces securities class action as CFO departs and production shifts

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Nano...

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, June  26, 2026  (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Nano-X Imaging Ltd. (&amp;#34;Nano-X&amp;#34; or the &amp;#34;Company&amp;#34;) (NASDAQ:NNOX) securities to contact Lauren Molinaro of</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Nano-X faces a securities class action alleging overstated efficiency gains and demand, with production misalignment. The company reported a Q4 2025 net loss of $33.4 million and a $17.5 million impairment tied to its Korean facility, while the CFO will depart on July 31, 2026. Management aims to reduce OpEx and shift to outsourced production, adding near-term margin pressure but potential efficiency gains if executed.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Lawsuit deadline for lead plaintiff: August 11, 2026.</li><li>Allegations: Nano-X overstated efficiency/demand; production misalignment.</li><li>Q4 2025: net loss $33.4M; $17.5M impairment at Korean facility; CFO to depart.</li><li>CEO: pursue reduced OpEx and outsourced production to cut cash burn.</li><li>Stock fell ~25% post-results; ongoing litigation risk weighs on sentiment.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Nano-X Imaging Ltd. (NNOX)</strong>: Subject of securities class action; litigation risk could pressure sentiment and valuation.</li><li><strong>Kirby McInerney LLP</strong>: Plaintiffs&#039; law firm leading the action; could influence settlement timing and disclosures.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. Fits due to securities litigation; the case could affect Nano-X&#039;s governance, financing options, and cost of capital as it unfolds.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Lead plaintiff deadline Aug 11, 2026 could spark volatility.</li><li>Q4 2025 results featured $33.4M net loss and $17.5M impairment; CFO transition.</li><li>April 2026 stock drop ~25% post-results reflects sentiment shock.</li><li>Outsourced production shift may improve cash burn but adds execution risk.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Class Period: March 31, 2025 through April 17, 2026.</li><li>Q4 2025 net loss: $33.4 million; impairment: $17.5 million at Korean facility.</li><li>CFO Ran Daniel to step down July 31, 2026.</li><li>Lead plaintiff deadline: August 11, 2026.</li><li>Stock drop: from $2.85 on April 17, 2026 to $2.15 on April 20, 2026 (~-25%).</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term bearish on litigation risk; potential upside if restructuring reduces burn, 6–12 months horizon.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">NEW YORK, June  26, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=WRB_gW3BjfkphTmUCmums6311EASNvUMOdbg_XAnYq-3seUXi75aP0zc-M9tGej_KRuBWrDUHsvGDFI1dqMHyyvKbsoqZczjj7V8qESHh_4=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> reminds investors who purchased Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/NNOX">NNOX</a>) securities to contact <a href="https://www.globenewswire.com/Tracker?data=QfUE0n0dZS9D77I0UFw-GwGxE9Woo0RoD9CY4ljgkYSSoXtPXwEp-xM1tTu8uWvc9-ep5uCps-lcvbKROZYeYEfNnsOpjqCP6bl177hft44-rPPpGG4rAJ3w_JESoDfz" rel="nofollow" target="_blank">Lauren Molinaro</a> of Kirby McInerney LLP by email at <a href="https://www.globenewswire.com/Tracker?data=FVl2HEGYdSCuB1cbUBv4zjMWUo5VFQyByeFVknE0MqBBQZP078gQv7f5-Cy7UBAHlz1Cj66f516vzTE4XBIUnoNm1ixL2sWp4pJnasOBOHfZrLv3O8jHkdHsNi_fg-zS" rel="nofollow" target="_blank">investigations@kmllp.com</a>, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.</p>  <p align="justify">If you suffered a loss on your Nano-X investments, you have until August 11, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements <a href="https://www.globenewswire.com/Tracker?data=WUwG6VvfJelb2bioKjM4Keg2obF4j-uunp54_jliSMPOFv2a2sqLD9-GascOXBPUoVsZ5GohAiX_lJgpSSyGOtQMhhE9Vgn3gnpsNuQz8wA=" rel="nofollow" target="_blank">here</a>.</p>  <p align="justify">Follow the link below for more information about the lawsuit:</p>  <p align="center">[<a href="https://www.globenewswire.com/Tracker?data=4Mb2MpTHV7YSRuymMv7sLAyyjEEzlPjQo_3uE0fGNX8dR0VMo3a9lZpfwX10K486Yzcih-uL8AXcbSKOQiJAGea45zlWqwEfYqAkAJL2IR0ZctQIc5WbZzWdpx8J6TpvuPxzN7aiRAl-J7WX2cuAUV8Bec5rrdIHc01mhQZS-aM=" rel="nofollow" target="_blank">CONTACT THE FIRM IF YOU SUFFERED A LOSS</a>]</p>  <p align="justify"><strong>What Is The Lawsuit About?</strong></p>  <p align="justify">The lawsuit has been filed on behalf of investors who purchased securities during the period of March 31, 2025 through April 17, 2026, inclusive ("the Class Period"). The lawsuit alleges that (i) Nano-X overstated purported efficiency gains achieved in its operations, as well as the purported increased demand for its products; (ii) in reality, Nano-X’s production and manufacturing operations were poorly aligned with demand for the Company’s products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; and (iv) the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges.</p>  <p align="justify">On April 20, 2026, Nano-X issued a press release announcing its Q4 2025 financial results and business updates. Nano-X reported, <em>inter alia</em>, a Q4 net loss of $33.4 million, mainly due to a $17.5 million charge attributed to impairment of long-lived assets following a restructuring initiative at its Korean chip manufacturing facility. In explaining the restructuring charge, the press release acknowledged that Nano-X needed to "shift[] to a more efficient outsourced production model that is better aligned with current and anticipated demand." The same press release also announced that Nano-X’s then-Chief Financial Officer ("CFO"), Ran Daniel, would step down as CFO, effective July 31, 2026. The same day, during a related earnings call to discuss these results, Nano-X’s Chief Executive Officer, Erez Meltzer, likewise disclosed that Defendants needed "to reduce our Korean operation’s OpEx [operating expenses] and cash burn and improve efficiency", while reiterating the need to "transition to a more efficient outsourced production model better aligned with current and projected demand." On this news, the price of Nano-X shares declined by $0.70 per share, or approximately 25%, from $2.85 per share on April 17, 2026 to close at $2.15 on April 20, 2026.</p>  <p align="center">[<a href="https://www.globenewswire.com/Tracker?data=Lq_L62Wmbtb4q9wQ4aG8lVMcRf5vZECIFtqllqOq7R63TMeC0gLTy-VRDRf-PqtNdmHxYmnLQWMuGgL7pdwubRccfVdcrB20hCu7mCbwSpxFxFN541ZYJh3UtYbOQDOIHFDhSiayVS6owujJRXfidauqxVpIDfEoT7_v1FAYV5RwUjDXVFn7KzCy91osSWQD" rel="nofollow" target="_blank">CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION</a>]</p>  <p align="justify"><strong>What Should I Do?</strong></p>  <p align="justify">If you purchased or otherwise acquired Nano-X securities, have information, or would like to learn more about this investigation, please contact <a href="https://www.globenewswire.com/Tracker?data=QfUE0n0dZS9D77I0UFw-G1glm0Yt-oKenD9bvntQzBD7ipIqbREY1g9e88G-cB3OLaOaO-NUE8Pp4up27yqKSsD2CPnxB107vqKJgY84GZC6ztvJA6iYVhWeqRCmzg3O" rel="nofollow" target="_blank">Lauren Molinaro</a> of <a href="https://www.globenewswire.com/Tracker?data=WRB_gW3BjfkphTmUCmums0ghD1X3izr32iAQ0JyfK0LZekrbSMOu1lk4XnYV5CfM2eLzFId46wlXLmjnrjnBIfbcBjZcIs5AR44Czzbx3OI=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> by email at <a href="https://www.globenewswire.com/Tracker?data=FVl2HEGYdSCuB1cbUBv4zjMWUo5VFQyByeFVknE0MqDxICRNRKsD4X5uLZ40eNJLIRwyhYZZWMSu7wXi46ZF1bYEGz2VV3-OlOe4lsLGQADbnrIHUbszdMryaSI5-ilj" rel="nofollow" target="_blank">investigations@kmllp.com</a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.</p>  <p align="center"><a href="https://www.globenewswire.com/Tracker?data=tXa2UeUpF1FWoxHFqamHIrT-ZJ5GOoKu0K9KaEyeAqt99m2yOojNLY7oExJEdXirkQX8c4BbdxwEDmL_9b1xypnyR6S0UgKfj8Bw-0jEOfLyTenBAAswHnMlUVg17gnp" rel="nofollow" target="_blank">[HOW CAN I PROTECT MY RIGHTS?]</a></p>  <p align="justify"><a href="https://www.globenewswire.com/Tracker?data=WRB_gW3BjfkphTmUCmums6311EASNvUMOdbg_XAnYq9RhsMuLX1hS6NeCru_yLFBxZn8DVjhKBGgaOgijgEWegEv114NM8pfAORrKx8_1TY=" rel="nofollow" target="_blank">Kirby McInerney LLP</a> is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s <a href="https://www.globenewswire.com/Tracker?data=OJiKqzLqvwiJ0g-_HnMqBTFBVvIbte-hwpkSESQYNAzHX1szl3h20iBDe8tM9CDyKA_SxoezLhFxIpbDW_LIPA==" rel="nofollow" target="_blank">website</a>.</p>  <p align="justify">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.</p>  <p align="justify">Contacts<br></br>Kirby McInerney LLP        <br></br>Lauren Molinaro, Esq.<br></br>212-699-1171<br></br><a href="https://www.globenewswire.com/Tracker?data=6A2bEflMNSEmZRiKMEXTZH-0Gz4Mk7gS2jZdEj-BDgiawRkmA4LQA-4zlU7ShemQ4c3wZfmDLd714AOlVfMNFTLL6nRBf_rPtvh4bjythoo=" rel="nofollow" target="_blank">https://www.kmllp.com</a><br></br><a href="https://www.globenewswire.com/Tracker?data=6A2bEflMNSEmZRiKMEXTZIeYVjCVgDQ28Ax6pajJsz20A-KO4dz1yIQVqqZ96SaiHjeUUUsJZPP6bMhFQRG3UE-J7_EMVhIalViInepF4jBIiwOEZX8hu5iqwXyc_PLPKKRVoHGgDmygSMT95cB-iA==" rel="nofollow" target="_blank">https://securitiesleadplaintiff.com/</a><br></br><a href="https://www.globenewswire.com/Tracker?data=FVl2HEGYdSCuB1cbUBv4zjMWUo5VFQyByeFVknE0MqAwuUCuJsUmfMoPHhHx0GIeqtlwTmERoR-JCz_78ABdrZNet0OOH93ryBdPeUrSm2xZMEeX43TLvLoRLBFkTytn" rel="nofollow" target="_blank">investigations@kmllp.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc1MzU1MSM3NjgxMDUzIzIwMjA2Njk="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NzgxMDI2MzktMTU1Mi00NDliLTg0NGYtMzYzOTUwYWU4NjY3LTEwMzE5OTctMjAyNi0wNi0yNi1lbg==/tiny/Kirby-McInerney-LLP.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/192da1d1-643f-4eee-b850-dde5b9f2b00f"><img src="https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png" border="0" width="147" height="147" alt="Primary Logo"></img></a></p>

Nano-X faces a securities class action alleging overstated efficiency gains and demand, with production misalignment. The company reported a Q4 2025 net loss of $33.4 million and a $17.5 million impairment tied to its Korean facility, while the CFO will depart on July 31, 2026. Management aims to reduce OpEx and shift to outsourced production, adding near-term margin pressure but potential efficiency gains if executed.

NNOX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Nano-X Imaging Ltd. Investors - Contact Kirby McInerney LLP by August 11, 2026

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News